Shandong Keyuan Pharmaceutical Co Ltd Class A 301281
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥20.69
- Day Range
- ¥20.68–21.95
- 52-Week Range
- ¥18.52–55.54
- Bid/Ask
- ¥21.64 / ¥21.67
- Market Cap
- ¥2.34 Bil
- Volume/Avg
- 3.0 Mil / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 59.70
- Price/Sales
- 5.08
- Dividend Yield (Trailing)
- 1.39%
- Dividend Yield (Forward)
- 1.39%
- Total Yield
- 1.39%
Company Profile
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and their preparations.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Growth
- Total Number of Employees
- 624
- Website
- http://www.keyuanpharm.com
Comparables
Valuation
|
Metric
|
301281
|
000919
|
603858
|
|---|---|---|---|
Price/Earnings (Normalized) | 59.70 | 58.45 | 36.15 |
Price/Book Value | 1.76 | 1.07 | 1.65 |
Price/Sales | 5.08 | 1.20 | 1.59 |
Price/Cash Flow | 22.92 | 15.61 | 17.05 |
Price/Earnings
301281
000919
603858
Financial Strength
|
Metric
|
301281
|
000919
|
603858
|
|---|---|---|---|
Quick Ratio | 5.53 | 3.28 | 0.48 |
Current Ratio | 6.72 | 3.61 | 1.28 |
Interest Coverage | — | 388.44 | 0.41 |
Quick Ratio
301281
000919
603858
Profitability
|
Metric
|
301281
|
000919
|
603858
|
|---|---|---|---|
Return on Assets (Normalized) | 2.91% | 1.25% | −0.45% |
Return on Equity (Normalized) | 3.20% | 1.83% | −0.83% |
Return on Invested Capital (Normalized) | 2.91% | 1.04% | −0.07% |
Return on Assets
301281
000919
603858
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Mrplcmwwqg | Cmqb | $790.4 Bil | |||
| Johnson & Johnson
JNJ
| Rqxksxcr | Xdq | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Xnzzcjsm | Pdz | $344.1 Bil | |||
| Merck & Co Inc
MRK
| Cxvhrhb | Mzjz | $288.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Rzgsbjws | Qpx | $258.7 Bil | |||
| AstraZeneca PLC ADR
AZN
| Gtqyhgxgp | Qmq | $242.3 Bil | |||
| Novartis AG ADR
NVS
| Fpxltwzz | Rcb | $234.2 Bil | |||
| Amgen Inc
AMGN
| Rzghjnlbbm | Rkl | $173.4 Bil | |||
| Pfizer Inc
PFE
| Cztbssskq | Cqtfp | $164.8 Bil | |||
| Sanofi SA ADR
SNY
| Bqzbgngs | Dgggt | $144.3 Bil |
United States